82 FR 30875 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 82, Issue 126 (July 3, 2017)

Page Range30875-30876
FR Document2017-13890

The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

Federal Register, Volume 82 Issue 126 (Monday, July 3, 2017)
[Federal Register Volume 82, Number 126 (Monday, July 3, 2017)]
[Notices]
[Pages 30875-30876]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-13890]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2016-N-2976; FDA-2016-N-3535; FDA-2013-N-1089; FDA-
2013-N-1619; FDA-2013-N-0719; FDA-2016-N-3586; FDA-2013-N-0796; FDA-
2016-N-0736; FDA-2016-N-3995; FDA-2013-D-0575; FDA-2016-N-0735]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of 
information collections that have been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A63, 11601 
Landsdown St., North Bethesda, MD 20852, (301) 796-7726, 
[email protected].

SUPPLEMENTARY INFORMATION: The following is a list of FDA information 
collections recently approved by OMB under section 3507 of the 
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control 
number and expiration date of OMB approval for each information 
collection are shown in table 1. Copies of the supporting statements 
for the information collections are available on the Internet at 
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.

        Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
                                            OMB control    Date approval
           Title of collection                  No.           expires
------------------------------------------------------------------------
Request for Information From U.S.              0910-0320       5/31/2020
 Processors That Export to the European
 Community..............................
Guidance for Industry: Special Protocol        0910-0470       5/31/2020
 Assessment.............................
Use of Symbols on Labels and in Labeling       0910-0553       5/31/2020
 of In Vitro Diagnostic Devices Intended
 for Professional Use...................
Current Good Manufacturing Practice in         0910-0606       5/31/2020
 Manufacturing, Packaging, Labeling, or
 Holding Operations for Dietary
 Supplements............................
Guidance for Industry: Planning for the        0910-0675       5/31/2020
 Effects of High Absenteeism to Ensure
 Availability of Medically Necessary
 Drug Products..........................

[[Page 30876]]

 
Focus Groups About Drug Products as Used       0910-0677       5/31/2020
 by the Food and Drug Administration....
Testing Communication on Medical Devices       0910-0678       5/31/2020
 and Radiation-Emitting Products........
Tracking Network for PETNet,                   0910-0680       5/31/2020
 LivestockNet, and SampleNet............
Medical Devices: Pediatric Uses of             0910-0748       5/31/2020
 Devices; Requirements for Submission of
 Information on Pediatric Subpopulations
 That Suffer From a Disease or Condition
 That a Device is Intended to Treat,
 Diagnose, or Cure......................
Guidance for Industry: Expedited               0910-0765       5/31/2020
 Programs for Serious Conditions--Drugs
 and Biologics..........................
Superimposed Text in Direct-to-Consumer        0910-0831       5/31/2020
 Promotion of Prescription Drugs........
------------------------------------------------------------------------


    Dated: June 27, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-13890 Filed 6-30-17; 8:45 am]
BILLING CODE 4164-01-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
ContactIla S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A63, 11601 Landsdown St., North Bethesda, MD 20852, (301) 796-7726, [email protected]
FR Citation82 FR 30875 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR